Expression of cAMP-responsive element binding protein and inducible cAMP early repressor in hyperfunctioning thyroid adenomas

Alessandro Peri, Paola Luciani, Massimo Tonacchera, Patrizia Agretti, Silvana Baglioni-Peri, Lisa Buci, Barbara Conforti, Federica Cioppi, Giancarlo Biliotti, Mario Serio, Paolo Vitti, Luca Chiovato

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: The pathogenesis of thyroid hyperfunctioning adenomas is still only partially understood and controversy exists about the frequency of gain-of-function mutations of the TSH receptor or Gsα gene, which activate the cAMP pathway. The nuclear transcription factors cAMP-responsive element binding protein (CREB) and inducible cAMP early repressor (ICER) are among the final targets of this signalling cascade. Design: In our study we focused on the expression of CREB and ICER genes in the nodular as well as in the extranodular tissue of hyperfunctioning tumours of the thyroid. Methods: RT-PCR and Western blot analysis were performed in a series of 14 patients. The presence of an activating mutation of the TSH receptor or of the Gsα gene was ascertained by direct sequencing. Results: The levels of CREB transcripts did not significantly differ in the adenomas and in the normal tissues (CREB/GAPDH, mean optical density ±S.E.: 0.98 ± 0.18 vs 0.88 ± 0.27 respectively, P = not significant (N.S.)), although case-to-case variability was observed. The absence of a significant difference between the adenoma and the surrounding normal tissue was maintained after dividing the patients into two groups, according to TSH receptor status. Accordingly, no significant difference in the levels of CREB protein (total and Ser133-phosphorylated) was observed between the nodular and the extranodular tissue. In addition, no difference was found in the levels of ICER transcripts (ICER/GAPDH, mean optical density±S.E.: 0.52 ± 0.11, nodule vs 0.36 ± 0.11, normal thyroid, P = N.S.), independently of the TSH receptor gene status (i.e. wild-type or mutated). Conclusions: Our results support the recent hypothesis that the activation of the cAMP pathway in hyperfunctioning adenomas of the thyroid might be counteracted by opposite events and suggest that complex molecular mechanisms might take part in the pathogenesis of hyperfunctioning tumours.

Original languageEnglish
Pages (from-to)759-766
Number of pages8
JournalEuropean Journal of Endocrinology
Volume146
Issue number6
Publication statusPublished - 2002

Fingerprint

Thyrotropin Receptors
Carrier Proteins
Adenoma
Genes
Thyroid Gland
Mutation
Neoplasms
Transcription Factors
Western Blotting
Hyperfunctioning Thyroid Adenoma
Polymerase Chain Reaction
Proteins

ASJC Scopus subject areas

  • Endocrinology

Cite this

Expression of cAMP-responsive element binding protein and inducible cAMP early repressor in hyperfunctioning thyroid adenomas. / Peri, Alessandro; Luciani, Paola; Tonacchera, Massimo; Agretti, Patrizia; Baglioni-Peri, Silvana; Buci, Lisa; Conforti, Barbara; Cioppi, Federica; Biliotti, Giancarlo; Serio, Mario; Vitti, Paolo; Chiovato, Luca.

In: European Journal of Endocrinology, Vol. 146, No. 6, 2002, p. 759-766.

Research output: Contribution to journalArticle

Peri, A, Luciani, P, Tonacchera, M, Agretti, P, Baglioni-Peri, S, Buci, L, Conforti, B, Cioppi, F, Biliotti, G, Serio, M, Vitti, P & Chiovato, L 2002, 'Expression of cAMP-responsive element binding protein and inducible cAMP early repressor in hyperfunctioning thyroid adenomas', European Journal of Endocrinology, vol. 146, no. 6, pp. 759-766.
Peri, Alessandro ; Luciani, Paola ; Tonacchera, Massimo ; Agretti, Patrizia ; Baglioni-Peri, Silvana ; Buci, Lisa ; Conforti, Barbara ; Cioppi, Federica ; Biliotti, Giancarlo ; Serio, Mario ; Vitti, Paolo ; Chiovato, Luca. / Expression of cAMP-responsive element binding protein and inducible cAMP early repressor in hyperfunctioning thyroid adenomas. In: European Journal of Endocrinology. 2002 ; Vol. 146, No. 6. pp. 759-766.
@article{0e358854c9b648a8b256540228e7ecda,
title = "Expression of cAMP-responsive element binding protein and inducible cAMP early repressor in hyperfunctioning thyroid adenomas",
abstract = "Objective: The pathogenesis of thyroid hyperfunctioning adenomas is still only partially understood and controversy exists about the frequency of gain-of-function mutations of the TSH receptor or Gsα gene, which activate the cAMP pathway. The nuclear transcription factors cAMP-responsive element binding protein (CREB) and inducible cAMP early repressor (ICER) are among the final targets of this signalling cascade. Design: In our study we focused on the expression of CREB and ICER genes in the nodular as well as in the extranodular tissue of hyperfunctioning tumours of the thyroid. Methods: RT-PCR and Western blot analysis were performed in a series of 14 patients. The presence of an activating mutation of the TSH receptor or of the Gsα gene was ascertained by direct sequencing. Results: The levels of CREB transcripts did not significantly differ in the adenomas and in the normal tissues (CREB/GAPDH, mean optical density ±S.E.: 0.98 ± 0.18 vs 0.88 ± 0.27 respectively, P = not significant (N.S.)), although case-to-case variability was observed. The absence of a significant difference between the adenoma and the surrounding normal tissue was maintained after dividing the patients into two groups, according to TSH receptor status. Accordingly, no significant difference in the levels of CREB protein (total and Ser133-phosphorylated) was observed between the nodular and the extranodular tissue. In addition, no difference was found in the levels of ICER transcripts (ICER/GAPDH, mean optical density±S.E.: 0.52 ± 0.11, nodule vs 0.36 ± 0.11, normal thyroid, P = N.S.), independently of the TSH receptor gene status (i.e. wild-type or mutated). Conclusions: Our results support the recent hypothesis that the activation of the cAMP pathway in hyperfunctioning adenomas of the thyroid might be counteracted by opposite events and suggest that complex molecular mechanisms might take part in the pathogenesis of hyperfunctioning tumours.",
author = "Alessandro Peri and Paola Luciani and Massimo Tonacchera and Patrizia Agretti and Silvana Baglioni-Peri and Lisa Buci and Barbara Conforti and Federica Cioppi and Giancarlo Biliotti and Mario Serio and Paolo Vitti and Luca Chiovato",
year = "2002",
language = "English",
volume = "146",
pages = "759--766",
journal = "European Journal of Endocrinology",
issn = "0804-4643",
publisher = "BioScientifica Ltd.",
number = "6",

}

TY - JOUR

T1 - Expression of cAMP-responsive element binding protein and inducible cAMP early repressor in hyperfunctioning thyroid adenomas

AU - Peri, Alessandro

AU - Luciani, Paola

AU - Tonacchera, Massimo

AU - Agretti, Patrizia

AU - Baglioni-Peri, Silvana

AU - Buci, Lisa

AU - Conforti, Barbara

AU - Cioppi, Federica

AU - Biliotti, Giancarlo

AU - Serio, Mario

AU - Vitti, Paolo

AU - Chiovato, Luca

PY - 2002

Y1 - 2002

N2 - Objective: The pathogenesis of thyroid hyperfunctioning adenomas is still only partially understood and controversy exists about the frequency of gain-of-function mutations of the TSH receptor or Gsα gene, which activate the cAMP pathway. The nuclear transcription factors cAMP-responsive element binding protein (CREB) and inducible cAMP early repressor (ICER) are among the final targets of this signalling cascade. Design: In our study we focused on the expression of CREB and ICER genes in the nodular as well as in the extranodular tissue of hyperfunctioning tumours of the thyroid. Methods: RT-PCR and Western blot analysis were performed in a series of 14 patients. The presence of an activating mutation of the TSH receptor or of the Gsα gene was ascertained by direct sequencing. Results: The levels of CREB transcripts did not significantly differ in the adenomas and in the normal tissues (CREB/GAPDH, mean optical density ±S.E.: 0.98 ± 0.18 vs 0.88 ± 0.27 respectively, P = not significant (N.S.)), although case-to-case variability was observed. The absence of a significant difference between the adenoma and the surrounding normal tissue was maintained after dividing the patients into two groups, according to TSH receptor status. Accordingly, no significant difference in the levels of CREB protein (total and Ser133-phosphorylated) was observed between the nodular and the extranodular tissue. In addition, no difference was found in the levels of ICER transcripts (ICER/GAPDH, mean optical density±S.E.: 0.52 ± 0.11, nodule vs 0.36 ± 0.11, normal thyroid, P = N.S.), independently of the TSH receptor gene status (i.e. wild-type or mutated). Conclusions: Our results support the recent hypothesis that the activation of the cAMP pathway in hyperfunctioning adenomas of the thyroid might be counteracted by opposite events and suggest that complex molecular mechanisms might take part in the pathogenesis of hyperfunctioning tumours.

AB - Objective: The pathogenesis of thyroid hyperfunctioning adenomas is still only partially understood and controversy exists about the frequency of gain-of-function mutations of the TSH receptor or Gsα gene, which activate the cAMP pathway. The nuclear transcription factors cAMP-responsive element binding protein (CREB) and inducible cAMP early repressor (ICER) are among the final targets of this signalling cascade. Design: In our study we focused on the expression of CREB and ICER genes in the nodular as well as in the extranodular tissue of hyperfunctioning tumours of the thyroid. Methods: RT-PCR and Western blot analysis were performed in a series of 14 patients. The presence of an activating mutation of the TSH receptor or of the Gsα gene was ascertained by direct sequencing. Results: The levels of CREB transcripts did not significantly differ in the adenomas and in the normal tissues (CREB/GAPDH, mean optical density ±S.E.: 0.98 ± 0.18 vs 0.88 ± 0.27 respectively, P = not significant (N.S.)), although case-to-case variability was observed. The absence of a significant difference between the adenoma and the surrounding normal tissue was maintained after dividing the patients into two groups, according to TSH receptor status. Accordingly, no significant difference in the levels of CREB protein (total and Ser133-phosphorylated) was observed between the nodular and the extranodular tissue. In addition, no difference was found in the levels of ICER transcripts (ICER/GAPDH, mean optical density±S.E.: 0.52 ± 0.11, nodule vs 0.36 ± 0.11, normal thyroid, P = N.S.), independently of the TSH receptor gene status (i.e. wild-type or mutated). Conclusions: Our results support the recent hypothesis that the activation of the cAMP pathway in hyperfunctioning adenomas of the thyroid might be counteracted by opposite events and suggest that complex molecular mechanisms might take part in the pathogenesis of hyperfunctioning tumours.

UR - http://www.scopus.com/inward/record.url?scp=0036307609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036307609&partnerID=8YFLogxK

M3 - Article

C2 - 12039695

AN - SCOPUS:0036307609

VL - 146

SP - 759

EP - 766

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

SN - 0804-4643

IS - 6

ER -